Seeing what alzheimer saw-with magnetic resonance microscopy

Fox1, Rossor

  • 1Dementia Research Group, The Institute of Neurology, University College London, 8-11 Queen Square, London, WC1N 3BG UKn.fox@dementia. ion.ud.ac.uk.

Nature Medicine
|December 29, 1999
PubMed

Insights

Detecting Alzheimer disease histopathology in living patients is closer. Researchers visualized amyloid plaques in autopsy samples using magnetic resonance microscopy, a key step for in vivo detection.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Biomarker Discovery

Background:

  • Alzheimer disease (AD) is characterized by amyloid plaques and neurofibrillary tangles.
  • Accurate in vivo detection of AD histopathology remains a significant challenge.
  • Current diagnostic methods often rely on late-stage clinical symptoms or invasive procedures.

Purpose of the Study:

  • To investigate the potential of magnetic resonance microscopy (MRM) for visualizing Alzheimer disease neuropathology.
  • To assess if MRM can detect amyloid plaques in post-mortem human brain tissue.

Main Methods:

  • Utilized high-resolution magnetic resonance microscopy.
  • Applied MRM to autopsy-derived human brain specimens.
  • Analyzed MRM data for the presence and distribution of amyloid plaques.

Main Results:

  • Successfully visualized amyloid plaques in autopsy specimens using MRM.
  • Demonstrated the capability of MRM to resolve microscopic pathological features.
  • This visualization represents a significant advancement in detecting AD hallmarks.

Conclusions:

  • Magnetic resonance microscopy shows promise for in vivo detection of Alzheimer disease histopathology.
  • This technique could lead to earlier and more accurate AD diagnosis.
  • Further research is warranted to translate this finding to clinical settings.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...